Several novel sulfonamide-derivatives were designed
and studied their physicochemical properties to develop novel kinase
inhibitors. Therefore, molecular docking was performed for the designed
compounds against epidermal growth factor receptor (PDB ID: 2ITY) to identify
new drug candidates for treating cancer. Binding free energy was calculated by
Molegro virtual docker (MVD) to select the most promising hits. The
corresponding docking score values into EGFR of 4b gave the best energy docking —128.819 Kcal/mol. The identified hits can serve as starting points for further
chemical synthesis and optimization to develop new potent anticancer agents.
References
[1]
Irfan, A., Batool, F., Irum, S., Ullah, S. and Umer, M. (2018) A Therapeutic Journey of Sulfonamide Derivatives as Potent Anti-Cancer Agents: A Review. World Journal of Pharmaceutical Research, 7, 257-270.
[2]
Peerzada, M.N., Khan, P., Ahmad, K., Hassan, M.I. and Azam, A. (2018) Synthesis, Characterization and Biological Evaluation of Tertiary Sulfonamide Derivatives of Pyridyl-Indole Based Heteroaryl Chalcone as Potential Carbonic Anhydrase IX Inhibitors and Anticancer Agents. European Journal of Medicinal Chemistry, 155, 13-23. https://doi.org/10.1016/j.ejmech.2018.05.034
[3]
Mohamed, H.R.S., Shaaban, M. and Heiba, H. (2012) Synthesis of New Thiazole Derivatives Bearing a Sulfonamide Moiety of Expected Anticancer and Radiosensitizing Activities.
[4]
Sudhakar, A. (2009) History of Cancer, Ancient and Modern Treatment Methods. Journal of Cancer Science and Therapy, 1, 1-4. https://doi.org/10.4172/1948-5956.100000e2
[5]
Tony, B.L. (2017) Phototherapy in Cancer Prevention and Treatment. Journal of Cancer Prevention & Current Research, 7, 22-24. https://doi.org/10.15406/jcpcr.2017.07.00224
[6]
Hamed, M.M. (2013) Design and Synthesis of Novel Quinazoline-Based EGFR Kinase Inhibitors and Dual EGFR/NF-κB Inhibitors as Potential Anti-Cancer Drugs with Enhanced Efficacy. Diss., Universität des Saarlandes, Saarbrücken, 1-141.
[7]
Abou El Ella, D.A., Ghorab, M.M., Noaman, E., Heiba, H.I. and Khalil, A.I. (2008) Molecular Modeling Study and Synthesis of Novel Pyrrolo[2,3-d]pyrimidines and Pyrrolotriazolopyrimidines of Expected Antitumor and Radioprotective Activities. Bioorganic & Medicinal Chemistry, 16, 2391-2402. https://doi.org/10.1016/j.bmc.2007.11.072
[8]
Seshacharyulu, P., Ponnusamy, M.P., Haridas, D., Jain, M., Ganti, A.K. and Batra, S.K. (2012) Targeting the EGFR Signaling Pathway in Cancer Therapy. Expert Opinion on Therapeutic Targets, 16, 15-31. https://doi.org/10.1517/14728222.2011.648617
[9]
Sangande, F., Julianti, E. and Tjahjono, D.H. (2020) Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR. International Journal of Molecular Sciences, 21, 7779. https://doi.org/10.3390/ijms21207779
[10]
Abuelizz, H.A., Marzouk, M., Ghabbour, H. and Al-Salahi, R. (2017) Synthesis and Anticancer Activity of New Quinazoline Derivatives. Saudi Pharmaceutical Journal, 25, 1047-1054. https://doi.org/10.1016/j.jsps.2017.04.022
[11]
Herbst, R.S. (2004) Review of Epidermal Growth Factor Receptor Biology. International Journal of Radiation Oncology, Biology, Physics, 59, 21-26. https://doi.org/10.1016/j.ijrobp.2003.11.041
[12]
Bethune, G., Bethune, D., Ridgway, N. and Xu, Z. (2010) Epidermal Growth Factor Receptor (EGFR) in Lung Cancer: An Overview and Update. Journal of Thoracic Disease, 2, 48-51.
[13]
Klebl, B., et al. (2011) Protein Kinases as Drug Targets. Wiley-VCH Verlag GmbH Co. KGaA, Weinheim.
[14]
Thirumurugan, K., Lakshmanan, S., Govindaraj, D., Daniel, D.S., Ramalakshmi, N. and Antony, S.A. (2018) Design, Synthesis and Anti-Inflammatory Activity of Pyrimidine Scaffold Benzamide Derivatives as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of Molecular Structure, 1171, 541-550. https://doi.org/10.1016/j.molstruc.2018.06.003
[15]
El-Deeb, I.M., Bayoumi, S.M., El-Sherbeny, M.A. and Abdel-Aziz, A.A.-M. (2010) Synthesis and Antitumor Evaluation of Novel Cyclic Arylsulfonylureas: ADME-T and Pharmacophore Prediction. European Journal of Medicinal Chemistry, 45, 2516-2530. https://doi.org/10.1002/chin.201039047
[16]
Saeedi, M., et al. (2014) Synthesis and Biological Investigation of Some Novel Sulfonamide and Amide Derivatives Containing Coumarin Moieties. Iranian Journal of Pharmaceutical Research, 13, 881-892.
[17]
Kaur, L., Arora, V., Arora, P. and Singh, M.P. (2018) A Review: Biological Significance of Sulfonamides. World Journal of Pharmacy and Pharmaceutical Sciences, 7, 413-422.
[18]
Kołaczek, A., Fusiarz, I., Lawecka, J. and Branowska, D. (2014) Biological Activity and Synthesis of Sulfonamide Derivatives: A Brief Review. Chemik, 68, 620-628.
[19]
Behmadi, H., Saadati, S.M., Roshania, M. and Ghaemy, M. (2009) Synthesis of New Disulfonamides from Different Substituted Diamino Pyridines. Eclética Química, 34, 27-31. https://doi.org/10.1590/S0100-46702009000300003
[20]
Rathish, I.G., et al. (2012) Synthesis and Evaluation of Anticancer Activity of Some Novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones. European Journal of Medicinal Chemistry, 49, 304-309. https://doi.org/10.1016/j.ejmech.2012.01.026
[21]
Shanti, K.D., Shanti, M.D. and Meshram, J.S. (2016) A Convenient Synthesis and Molecular Docking Study of Novel Sulfonamides Fused with Betti’s Bases as DNA Topoisomerase II Inhibitors. Journal of Computational Methods in Molecular Design, 6, 13-19.
[22]
Rawal, K., et al. (2019) An Extensive Survey of Molecular Docking Tools and Their Applications Using Text Mining and Deep Curation Strategies. PeerJ Preprints, 7, e27538v1. https://doi.org/10.7287/peerj.preprints.27538
[23]
Pinzi, L. and Rastelli, G. (2019) Molecular Docking: Shifting Paradigms in Drug Discovery. International Journal of Molecular Sciences, 20, 1-23. https://doi.org/10.3390/ijms20184331
[24]
Meng, X.-Y., Zhang, H.-X., Mezei, M. and Cui, M. (2012) Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery. Current Computer-Aided Drug Design, 7, 146-157. https://doi.org/10.2174/157340911795677602
[25]
Christensen, M.H. (2006) MolDock: A New Technique for High-Accuracy Molecular Docking. Journal of Medicinal Chemistry, 49, 3315-3321. https://doi.org/10.1021/jm051197e
[26]
Ihmaid, S., Ahmed, H.E.A. and Zayed, M.F. (2018) The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization. International Journal of Molecular Sciences, 19, 408. https://doi.org/10.3390/ijms19020408
[27]
Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2012) Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Advanced Drug Delivery Reviews, 64, 4-17. https://doi.org/10.1016/j.addr.2012.09.019
[28]
Naaz, F., et al. (2018) Molecular Modeling, Synthesis, Antibacterial and Cytotoxicity Evaluation of Sulfonamide Derivatives of Benzimidazole, Indazole, Benzothiazole and Thiazole. Bioorganic & Medicinal Chemistry, 26, 3414-3428. https://doi.org/10.1016/j.addr.2012.09.019
